Monday, August 17, 2026
21
C
Bengaluru
Hot topics
Strategic Communications for Healthcare Brands
In a sector where credibility is currency, how your...
Geo-Fencing / Shadow Messaging – Hook for Pharma Marketers
In the dynamic world of pharmaceutical marketing, staying ahead of the curve is essential for success. As technology continues to evolve, so do the opportunities for innovative campaigns. One area where pharma marketers can make a significant impact is in raising awareness about non-communicable diseases (NCDs) and promoting real-world studies and clinical trials.
Crafting a Digital Strategy: The Roadmap for 2021
In many situations, technology upgradation is often construed as digital transformation. In a recently conducted survey by Altimeter, 88% of companies said that they were undergoing ‘digital transformation’ but only 25% said that they did so with the purpose beyond investing in new technology. The real definition of digital transformation is the realignment of, or new investment in technology, business models, and processes to create value for customers in a dynamic digital economy.
American Tariffs and The Rise of the Corporate Superpower
From Nation-States to Corporate Titans: How Innovation is Redrawing...
IMS Health Market Reflection Report for September 2016
The Indian Pharmaceutical Market (IPM) was valued at Rs. 10,278 crs in the month of September 2016 clocking a strong 10% growth over same period last year (SPLY). On a MAT September basis, the industry was valued at Rs. 111,022 crores and reflected a 13% growth with volumes contributing around 40% of this growth and New Introductions playing an important role with around 38% contribution to the overall growth.
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Hot topics
Brecht Vanneste has been appointed as Managing Director of MSD India
He steps into the role with a clear mandate...
Has the Pharmacy of the World Missed the Animal Health Bus?
In 2025, the Indian animal health market stood at...
Fifth Aniversary Issue
Digital in Pharma Special Issue with Digital Marketing Case Study on Janssen's Me Without Migraine patient awareness campaign.
Interesting, Engaving & Relevant
In this issue Deepak Sharma talks about his journey from Medical Rep to Country Manager. Deeksha Fouzdar presents a case study on implementation of a competency-based HR system in Pharma. Other articles by K. Hariram and Vivek Hattangadi
Pharma in the New Normal
2020 has been a challenging year for all industries. For pharma and its HCP customers even more so. All eyes are on the companies developing vaccines and drugs for treatment of COVID-19, while doctors have closed their doors for pharma reps. Long established processes have been disrupted and complex market strategies have been rendered useless. Each pharma no matter big or small, innovative, or generic, had to improvise and come up with contingency plans to save the year. Some have been slower waiting for the old ways to come back, others have been more agile experimenting with digital and expanding boundaries, most are in the middle digitally curious but not risking too much.
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Kailash Joshi has been appointed as Executive Director – Analytics, Insights & Decision Enablement (US) at Novartis, as part of the Novartis Global Capability...
With extensive experience across commercial excellence, analytics, insights, AI-driven...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Will President Trump’s Diktat Improve Drug Quality For Indian Patients?
Executive Summary
The geopolitical landscape of pharmaceutical manufacturing is shifting...
Mounjaro is the Exceptional Growth Story: Ranks #1
The July Brand Monitor by Pharmarack shows a healthy...
Sun Pharma: In the Eye of the Storm of Ophthalmologists
The Two-Tier Reality of Indian Pharma: Patient Safety, Pharmacovigilance,...
Newsletter
Get important news delivered directly to your inbox and stay connected!